Engene Therapeutics Inc (ENGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 10/31
| 01-2025 | 10-2024 | 07-2024 | 04-2024 | 01-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 62,346 | 173,004 | 257,678 | 264,810 | 85,646 |
| Marketable Securities | 151,542 | 65,400 | 75 | 75 | 79 |
| Receivables | 430 | 332 | 241 | 1,213 | 1,130 |
| TOTAL | $222,320 | $247,362 | $262,694 | $269,609 | $89,577 |
| Non-Current Assets | |||||
| PPE Net | 1,366 | 1,169 | 1,014 | 1,107 | 993 |
| Investments And Advances | 58,979 | 59,527 | 0 | 0 | 0 |
| Other Non-Current Assets | 3,267 | 3,115 | 3,171 | 2,812 | 2,851 |
| TOTAL | $63,612 | $63,811 | $4,185 | $3,919 | $3,844 |
| Total Assets | $285,932 | $311,173 | $266,879 | $273,528 | $93,421 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,605 | 1,411 | 2,862 | 211 | 1,275 |
| Accrued Expenses | 8,244 | 12,128 | 8,833 | 5,667 | 5,237 |
| TOTAL | $12,955 | $14,661 | $13,458 | $6,299 | $6,905 |
| Non-Current Liabilities | |||||
| Long Term Debt | 21,696 | 22,473 | 21,612 | 22,730 | 22,529 |
| Other Non-Current Liabilities | 1,331 | 1,427 | 1,480 | 1,533 | 1,602 |
| TOTAL | $23,027 | $23,900 | $23,092 | $24,263 | $24,131 |
| Total Liabilities | $35,982 | $38,561 | $36,550 | $30,562 | $31,036 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 50,978 | 50,977 | 44,216 | 44,166 | N/A |
| Common Shares | 509,812 | 509,811 | 453,479 | 453,405 | 259,373 |
| Retained earnings | -279,346 | -254,730 | -239,431 | -225,283 | -210,299 |
| Other shareholders' equity | -1,275 | -1,419 | -1,016 | -1,016 | -1,016 |
| TOTAL | $249,950 | $272,612 | $230,329 | $242,966 | $62,385 |
| Total Liabilities And Equity | $285,932 | $311,173 | $266,879 | $273,528 | $93,421 |